Australian Immunisation Handbook, 8th Edition – 9/2003
The new immunisation schedule (Table 1.7.1) incorporates all
vaccines recommended as 'best practice'. Immunisation providers are responsible
for advising patients and parents/caregivers of available vaccine choices at
the time of consultation, including those provided free under the National
Immunisation Program. Information about the National Immunisation Program can
be obtained from your State or Territory health authority.
|
AGE |
VACCINE
|
||||||||
|
B
i r t h |
Hepatitis B1 |
|
|
|
|
|
|
|
|
|
2 months |
Hepatitis B2,3 |
DTPa |
Hib1,2 |
IPV |
|
|
7vPCV |
|
|
|
4 months |
Hepatitis B2,3 |
DTPa |
Hib1,2 |
IPV |
|
|
7vPCV |
|
|
|
6 months |
Hepatitis B2 |
DTPa |
Hib1 |
IPV |
|
|
7vPCV |
|
|
|
12 months |
Hepatitis B3 |
|
Hib1,2 |
|
MMR |
|
|
MenCCV |
|
|
18 months |
|
|
|
|
|
VZV |
23vPPV1 |
|
|
|
2 years |
|
|
|
|
|
|
|
|
|
|
4 years |
|
DTPa |
|
IPV |
MMR |
|
|
|
|
|
10 – 13 years |
Hepatitis B4 |
|
|
|
|
VZV1 |
|
|
|
|
15 – 17 years |
|
dTpa |
|
|
|
|
|
|
|
|
50 years & over |
|
dT |
|
|
|
|
23vPPV2 |
|
Influenza(annual)2 |
|
65 years & over |
|
|
|
|
|
|
23vPPV |
|
Influenza(annual) |
Schedule key
|
Hepatitis
B1 |
Monovalent
hepatitis B vaccine. |
|
Hepatitis
B2 |
Hepatitis
B vaccine given as either monovalent vaccine or in combination with DTPa, 3
doses at 2, 4 and 6 months, in addition to the birth dose for a total of 4
doses |
|
Hepatitis
B3 |
Hepatitis
B vaccine in combination with Hib (PRP-OMP), 3 doses at 2, 4 and 12 months,
in addition to the birth dose for a total of 4 doses. |
|
Hepatitis
B4 |
Hepatitis
B vaccine for 10 to 13 year olds who have not received a primary course |
|
Hib1 |
PRP-T,
HbOC (non-Indigenous children). |
|
Hib2 |
PRP-OMP
(all children). |
|
23vPPV1 |
Pneumococcal
polysaccharide vaccine (Aboriginal and Torres Strait Islander children only);
this dose can be given between 18 months and 2 years of age (refer to State/Territory
Public Health Units for recommended age for administration). |
|
23vPPV2
& Influenza2 |
National
Indigenous Pneumococcal and Influenza Immunisation Program. |
|
VZV1 |
Vaccination
only for children with a negative history of varicella disease or
vaccination. |
Notes: Aboriginal and Torres Strait Islander children receive
3 doses of PRP-OMP Hib vaccine.
Non-Indigenous children can receive 3 doses of PRP-OMP
Hib vaccine or 4 doses of either PRP-T or HbOC Hib vaccine. (Mixing Hib
schedules is not recommended. Infants starting with PRP-OMP should continue
with PRP-OMP.)
Adolescent hepatitis B and VZV are not required if a
primary vaccination course has been given in early childhood.
Access to free pneumococcal conjugate vaccine is
provided to the following groups; all Aboriginal and Torres Strait Islander
children aged up to 2 years, Aboriginal children in central Australia aged up
to 5 years, non-Indigenous children in central Australia aged up to 2 years,
and all children under 5 years with medical risk factors that predispose them
to high rates or high severity of pneumococcal infection.
IPV is preferred to OPV, subject to
the availability of IPV-combination vaccines, but both IPV and OPV are
acceptable for use in the ASVS
|
Hepatitis B |
Hepatitis B vaccine |
|
DTPa |
Diphtheria-tetanus-acellular pertussis infant/child
formulation |
|
dTpa |
Adult/adolescent formulation diphtheria-tetanus- acellular
pertussis vaccine |
|
Hib |
Haemophilus influenzae type b (Hib) vaccine PRP-OMP,
PRP-T, HbOC (as monovalent or in combination) |
|
IPV |
Inactivated poliomyelitis vaccine (in combination) |
|
MMR |
Measles-mumps-rubella vaccine |
|
VZV |
Varicella-zoster vaccine |
|
7vPCV |
7-valent pneumococcal conjugate vaccine |
|
23vPPV |
23-valent pneumococcal polysaccharide vaccine |
|
MenCCV |
Meningococcal C conjugate vaccine |
|
Influenza |
Influenza vaccine |
|
dT |
Adult
diphtheria-tetanus vaccine. |